I came to London to report about higher education but I stayed for the austerity.

AstraZeneca’s Soriot Asks for Patience as Pfizer Return Looms

bloomberg.com — AstraZeneca Plc (AZN) Chief Executive Officer Pascal Soriot asked investors for patience with his growth strategy as he outlined drug development plans a week before Pfizer Inc. (PFE) is allowed to make another takeover attempt. The U.K. drugmaker remains committed to increasing revenue 75 percent to $45 billion by 2023, Soriot said at a presentation for investors today.

AstraZeneca raises forecast on lack of Nexium competition

delawareonline.com — AstraZeneca Plc, the drugmaker that fought off a takeover attempt by Pfizer Inc., has raised its forecasts for the second time this year after competition for one of its top-selling medicines failed to materialize.

AstraZeneca share rise shows value, says CEO

philly.com — Posted: Friday, November 7, 2014, 1:08 AM AstraZeneca P.L.C.'s stock has climbed to the price that Pfizer Inc. initially offered to buy the United Kingdom drugmaker, indicating the company can create value without a buyout, chief executive officer Pascal Soriot said.

AstraZeneca Is Building Value Without Pfizer, CEO Says

bloomberg.com — AstraZeneca Plc (AZN)'s stock has climbed to the price that Pfizer Inc. (PFE) initially offered to buy the U.K. drugmaker, indicating the company can create value without a buyout, Chief Executive Officer Pascal Soriot said.

AstraZeneca Raises Forecast on Lack of Nexium Competitor

bloomberg.com — AstraZeneca Plc (AZN), the U.K. drugmaker that fought off a takeover attempt by Pfizer Inc., raised its forecasts for the second time this year after competition for one of its top-selling medicines failed to materialize as expected.

Glaxo Considers ViiV IPO to Capitalize on HIV-Drug Sales

bloomberg.com — GlaxoSmithKline Plc (GSK) is exploring an initial public offering for its Viiv Healthcare Ltd. subsidiary to capitalize on the unit's soaring sales of HIV drugs even as revenue for the parent company declines. Glaxo is considering the sale of a minority stake, the London-based pharmaceutical maker said in a statement today.

Glaxo Pledges to Cut Costs After Earnings Beat Estimates

bloomberg.com — GlaxoSmithKline Plc (GSK), the U.K.'s biggest drugmaker, reported third-quarter earnings that beat analyst estimates, even as currency effects and sluggish sales of its respiratory drugs in the U.S. hurt profit. Profit excluding certain items fell 1 percent to 1.89 billion pounds ($3 billion), or 27.9 pence a share, the London-based company said today in a statement.

Bloomberg Briefs

bloombergbriefs.folioshack.com — Highclere Thoroughbred Racing, the syndicate that owned former Royal Ascot winner Harbinger, is experiencing strong demand even as higher prices for young racehorses push up costs, managing director Alex Smith said. Highclere, founded in 1992 to put together ownership groups for racehorses, has produced seven champions, including top-rated Harbinger in 2010.

J&J Says 250,000 Ebola Vaccine Doses to Be Ready by May

bloomberg.com — Johnson & Johnson (JNJ) plans to have 250,000 doses of an experimental Ebola vaccine ready for use in clinical trials in May, accelerating the effort to find protection from the virus that has killed thousands of people in West Africa.

Glaxo Rising Star Connelly Under Pressure as Drugs Falter

bloomberg.com — Deirdre Connelly became a rising star at GlaxoSmithKline Plc (GSK) by helping the company survive a scandal. Her future may be clouded by a more basic challenge: Glaxo's struggle to sell medicine in its biggest market. Glaxo's U.S. pharmaceutical sales have fallen 16 percent since 2009, when Connelly, 54, took over as head of North American pharmaceuticals.
More Articles →
Nov 21, 2014

@JackFeerick So I guess he favors letting Martha and Thomas Wayne live?

Nov 20, 2014

@timeshighered Funny division: Straight Man, by Richard Russo. Serious dvision: Disgrace, JM Coetzee #BestHEnovel

Nov 20, 2014

Also: only mammals to use Internet RT @DLeonhardt "We are the only mammals that consume milk after childhood nytimes.com/2014/11/18/ups…

Nov 19, 2014

Here's a list of the highest paid college professors, led by $7.2M for .. wait. sorry, these are football coaches sports.usatoday.com/ncaa/salaries/

Nov 19, 2014

@SportsCenter Maybe when your start-up sports network makes some money you can afford to rent an indoor studio

Nov 19, 2014

The Lakers aren't who you think MT @SportsCenter Five of top six scorers in NBA history played for Lakers at some point. Other one is Jordan

Nov 19, 2014

RT @JacobEPVantage: $CLVS vs $AZN: neck and neck, but $CLVS has more to lose. My take, via @EPVantage: ow.ly/ExrTo

Nov 19, 2014

Billionaire stock activist Bill Ackman now has animal health company Zoetis in his sights. bloomberg.com/news/2014-11-1…



Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.

Email

For instructions on how to pitch Oliver Staley, email ostaley@muckrack.com.


Share This Profile